hioscar.com (OSCR): EV/EBITDA Multiple

Oscar Health, Inc. (OSCR) is gradually building cash flow stability as medical costs constrain free cash flow, and the GURU.Markets terminal provides a chart of the current EV/EBITDA valuation, where this metric equals 0.00. The company is disrupting the health insurance market via its AI platform, aggressively expanding its individual plans base. Demand is growing by attracting a digital audience within US government programs.

OSCR Oscar Health Inc: Company Value to EBITDA in the range 11/23/2025 - 11/15/2026

Summary analytical data breakdowns for Oscar Health (OSCR)

- market price and analyst price targets:

Price Chart Oscar Health Corp|OSCR - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Capitalization Oscar|OSCR - Value Adjusted for Debt and Cash

- issuer book value statistics:

Net Assets per Single Share Oscar Health|OSCR - Total Stockholders' Equity|Market Value to Book Value Ratio hioscar.com|OSCR - Company Total Asset Base

- debt and solvency information:

- business earnings and investment ratios data:

OSCR - Final Profit|Projected Future Earnings Oscar Health, Inc.|OSCR - Market Cap to Earnings|Forward P/E Multiple hioscar.com|OSCR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Oscar Health, Inc.|OSCR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Oscar Health|OSCR - Earnings per share for the last four quarters|Quarterly EPS earnings growth hioscar.com|OSCR - Earnings per share increase in current year|Expected earnings per share growth for next year Oscar Health, Inc.

- revenue and sales details:

OSCR - Company Sales Revenue|Projected Sales Volume hioscar.com|OSCR - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Oscar Health Inc|OSCR - Sales Growth YoY (Last 12 Months)

Fundamental company analysis:OSCR (Oscar Health, Inc.)

Oscar Health, Inc. (OSCR) attracts a younger audience through its technological superiority, which necessitates precise control over capital intensity during scaling. By analyzing the historical EV/EBITDA trajectory, an investor compares the enterprise value—accounting for debt and taxes—to operating profit to determine whether the current price reflects a market discount or signals a systemic degradation of the company's fundamentals.

Key competitors

EV/EBITDA Multiple UNH (UnitedHealth Group)|Enterprise Value to Operating Income Before Depreciation Ratio CI (The Cigna Group)|aflac.com - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation HUM (Humana Health)|CNC: EV/EBITDA Multiple|Company Value to EBITDA Molina Corp (MOH)|Enterprise Value to EBITDA Ratio MMS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CLOV|EV/EBITDA Multiple CTEV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization YB (Yuanbao)|Health In Tech - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple eHealth, Inc. EHTH|GoHealth Insurance - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation NEUE (neuehealth.com)|Reliance Global (RELI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA MSP Recovery (LIFW)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MultiPlan Corp.